Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease - PubMed (original) (raw)
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease
F Colciaghi et al. Neurology. 2004.
Abstract
Amyloid precursor protein (APP), ADAM 10, and beta-site-APP cleaving enzyme (BACE) alterations were evaluated in platelets of 31 patients with Alzheimer disease (AD) and 15 age-matched controls. A significant modification of these proteins and enzymes involved in the amyloid cascade was detected from the earliest clinically detectable disease stage. This observation suggests that AD is associated with an early metabolic derangement toward amyloidogenic pathways and supports the potential value of APP and secretase measurements for early diagnosis of AD.
Similar articles
- Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.
Tang K, Hynan LS, Baskin F, Rosenberg RN. Tang K, et al. J Neurol Sci. 2006 Jan 15;240(1-2):53-8. doi: 10.1016/j.jns.2005.09.002. Epub 2005 Oct 26. J Neurol Sci. 2006. PMID: 16256140 Free PMC article. - [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients.
Colciaghi F, Borroni B, Pastorino L, Marcello E, Zimmermann M, Cattabeni F, Padovani A, Di Luca M. Colciaghi F, et al. Mol Med. 2002 Feb;8(2):67-74. Mol Med. 2002. PMID: 12080182 Free PMC article. - Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients.
Bram JMF, Talib LL, Joaquim HPG, Sarno TA, Gattaz WF, Forlenza OV. Bram JMF, et al. Eur Arch Psychiatry Clin Neurosci. 2019 Dec;269(8):963-972. doi: 10.1007/s00406-018-0905-3. Epub 2018 May 29. Eur Arch Psychiatry Clin Neurosci. 2019. PMID: 29845446 - Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease.
Johnston JA, Liu WW, Todd SA, Coulson DT, Murphy S, Irvine GB, Passmore AP. Johnston JA, et al. Biochem Soc Trans. 2005 Nov;33(Pt 5):1096-100. doi: 10.1042/BST20051096. Biochem Soc Trans. 2005. PMID: 16246054 Review. - A portrait of Alzheimer secretases--new features and familiar faces.
Esler WP, Wolfe MS. Esler WP, et al. Science. 2001 Aug 24;293(5534):1449-54. doi: 10.1126/science.1064638. Science. 2001. PMID: 11520976 Review.
Cited by
- One immune cell to bind them all: platelet contribution to neurodegenerative disease.
Rodriguez Moore G, Melo-Escobar I, Stegner D, Bracko O. Rodriguez Moore G, et al. Mol Neurodegener. 2024 Sep 27;19(1):65. doi: 10.1186/s13024-024-00754-4. Mol Neurodegener. 2024. PMID: 39334369 Free PMC article. Review. - Predicting the Cognitive Ability of Young Women Using a New Feature Selection Algorithm.
Arzehgar A, Davarinia F, Ferns GA, Hakimi A, Bahrami A. Arzehgar A, et al. J Mol Neurosci. 2023 Aug;73(7-8):678-691. doi: 10.1007/s12031-023-02145-8. Epub 2023 Aug 15. J Mol Neurosci. 2023. PMID: 37581703 - Shifting the balance: soluble ADAM10 as a potential treatment for Alzheimer's disease.
Hershkovits AS, Gelley S, Hanna R, Kleifeld O, Shulman A, Fishman A. Hershkovits AS, et al. Front Aging Neurosci. 2023 May 17;15:1171123. doi: 10.3389/fnagi.2023.1171123. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37266401 Free PMC article. - Effects of the interactions between platelets with other cells in tumor growth and progression.
Li Y, Wang H, Zhao Z, Yang Y, Meng Z, Qin L. Li Y, et al. Front Immunol. 2023 Apr 17;14:1165989. doi: 10.3389/fimmu.2023.1165989. eCollection 2023. Front Immunol. 2023. PMID: 37153586 Free PMC article. Review. - Aβ1-42-containing platelet-derived extracellular vesicle is associated with cognitive decline in Parkinson's disease.
Wang Z, Zheng Y, Cai H, Yang C, Li S, Lv H, Feng T, Yu Z. Wang Z, et al. Front Aging Neurosci. 2023 Apr 14;15:1170663. doi: 10.3389/fnagi.2023.1170663. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37122378 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical